cyclic
guanosin
monophosph
cgmp
import
cyclic
nucleotid
play
critic
role
signal
transduct
mani
differ
signal
transduct
eukaryot
cell
essenti
moder
transmiss
inform
cell
membran
second
messeng
cgmp
regul
numer
essenti
process
cell
amplifi
extern
signal
exampl
hormon
neurotransmitt
cytosol
cgmp
bind
cyclic
nucleotideg
ion
phosphoryl
protein
kinas
g
pkg
amiloridesensit
epitheli
sodium
channel
enac
behav
ligandg
channel
similar
sever
member
enacdegenerin
late
part
renal
distal
convolut
tubul
sodium
predomin
reabsorb
via
electrogen
amiloridesensit
enac
connect
tube
collect
duct
enac
pathway
retain
salt
enac
control
renal
sodium
excret
provid
drive
forc
potassium
secret
renal
outer
medullari
potassium
lossoffunct
enac
genet
variant
lead
low
blood
pressur
gainoffunct
mutant
identifi
liddl
syndrom
character
increas
enac
abund
augment
open
time
consequ
salt
retent
eventu
volumeexpend
autosom
recess
form
pseudohypoaldosteron
type
caus
mutat
enac
usual
sever
persist
multiorgan
symptom
five
enac
subunit
clone
date
name
among
regul
channel
activ
selfconduct
subunit
heterolog
express
oocyt
cell
line
lumin
imperm
reagent
hormon
confirm
regul
enac
lung
kidney
colon
enac
regul
spectrum
protein
kinas
pkg
protein
kinas
pka
howev
understand
cellular
molecular
mechan
cgmp
regul
enac
incomplet
cyclic
gmp
one
promin
nucleotid
eukaryot
cell
guanylyl
cyclas
elev
cell
cgmp
level
regul
complex
signal
cascad
immedi
downstream
effector
cgmpdepend
protein
kinas
cyclic
nucleotideg
ion
channel
cptcgmp
deriv
analog
parent
cgmp
long
use
studi
nocgmppkg
cascad
regul
epitheli
sodium
channel
cptcgmp
camp
analog
summar
tabl
speci
culturedepend
enac
properti
strategi
use
elev
cell
cgmp
content
includ
nitric
oxid
donor
pkg
isoformspecif
cgmp
analog
may
contribut
diverg
observ
date
three
pkg
isoform
isol
name
pkgii
accumul
evid
genet
engin
anim
suggest
cardiovascular
phenotyp
predomin
pkgi
knockout
pkgii
defici
lead
dysfunct
epitheli
tissu
result
use
uss
chamber
voltag
clamp
techniqu
show
increas
amiloridesensit
shortcircuit
current
across
cell
monolay
also
increas
heterolog
express
activ
dosedepend
manner
probabl
stimul
pkgii
enzymat
activ
subsequ
activ
channel
function
figur
carton
briefli
show
interact
cgmp
enac
figur
recent
studi
show
pkginteract
protein
mediat
cellular
target
pkg
isoform
interact
leucin
zipper
domain
protein
recognit
mediat
surfac
charg
interact
sharp
contrast
nativ
enac
heterolog
express
oocyt
consid
camppkaindepend
particularli
acut
regul
cellperm
pkgii
isoformspecif
activ
acut
stimul
human
rat
mous
revers
furthermor
intraoocyt
domain
enac
subunit
tradit
solubl
protein
kinas
may
target
compound
critic
extracellular
domain
recent
identifi
bind
site
indic
extracellular
ligand
enac
moreov
stimul
approxim
coexpress
channel
confer
cptcampmedi
activ
concentr
maxim
effect
valu
similar
channel
extern
sodium
selfinhibit
intrins
featur
enac
rapidli
increas
extracellular
sodium
ion
physiolog
concentr
mm
mammal
amphibian
gener
maxim
peak
current
second
permeabl
enac
na
ion
gradual
reduc
rel
stabl
level
current
level
approxim
half
maxim
valu
phenomenon
call
extracellular
sodium
selfinhibit
enac
activ
differ
downregul
enac
activ
slowli
accumul
intracellular
na
content
feedback
manner
extern
na
selfinhibit
crucial
mechan
limit
overwhelm
salt
absorpt
prevent
quick
rais
epitheli
cell
volum
blood
pressur
maintain
salt
fluid
homeostasi
lumin
surfac
respiratori
system
keep
normal
cilia
beat
airway
hyperpolar
apic
membran
fine
adjust
fluid
volum
host
leukocyt
physiolog
regul
forefront
battl
noxiou
aspir
insult
previou
studi
show
extern
cptcamp
stimul
human
rat
murin
dosedepend
extern
sodium
concentrationdepend
fashion
enac
mutat
abolish
selfinhibit
almost
complet
elimin
cptcamp
mediat
activ
contrast
mutat
enhanc
selfinhibit
elev
cptcamp
sensit
increas
stimul
effect
compound
data
confirm
cptcamp
act
ligand
regul
heterolog
enac
reliev
selfinhibit
edelheit
et
al
studi
alanin
mutat
conserv
charg
residu
enac
found
residu
involv
conform
chang
lead
channel
constrict
sodium
selfinhibit
respons
upon
sodium
ion
flood
similarli
recent
data
show
elimin
selfinhibit
may
novel
mechan
cptcgmp
stimul
salt
reabsorpt
human
epithelium
figur
cptcgmp
analog
cptcamp
capabl
activ
enac
ident
manner
cellfre
outsideout
patch
point
mutat
put
consensu
pkg
phosphoryl
site
truncat
entir
cytosol
coohtermin
tail
enac
alter
respons
cptcgmp
enac
activ
activ
extent
cptcgmp
cell
pkgii
express
knock
use
small
interf
rna
demonstr
parachlorophenylthio
moieti
ribos
group
cptcgmp
crucial
activ
enac
cptcgmp
may
serv
novel
enac
ligand
addit
activ
pkg
signal
strict
requir
parachlorophenylthio
ribos
group
help
clarifi
basi
inconsist
result
observ
regul
enac
varieti
cgmp
analog
figur
previou
experi
construct
mutant
abolish
augment
enac
selfinhibit
mutat
elimin
selfinhibit
result
loss
respons
cptcgmp
wherea
enhanc
selfinhibit
facilit
stimulatori
effect
compound
figur
show
potenti
bind
site
cptcgmp
ligand
enac
domain
crucial
selfinhibit
locat
center
palm
region
subunit
locat
vicin
put
bind
site
proton
domain
potenti
directli
alloster
interact
cptcgmp
previou
result
suggest
extern
rapidli
revers
activ
enac
dosedepend
manner
reliev
channel
sodium
addit
zn
extracellular
chlorid
halogen
gase
sulfhydryl
groupmodifi
reagent
eg
pchloromercuriphenylsulfon
pcmp
pchloromercuribenzo
pcmb
pchloromercuribenzo
benzimidazolylguanidin
proton
cupper
proteas
also
propos
modul
enacg
reliev
sodium
selfinhibit
classic
earlier
review
summar
noncleav
channel
low
intrins
open
probabl
may
reflect
enhanc
channel
inhibit
extern
sodium
cleavag
minimum
two
site
within
subunit
requir
activ
channel
presum
releas
inhibitori
fragment
extent
enac
proteolysi
depend
channel
resid
time
plasma
membran
well
balanc
level
express
proteas
activ
epitheli
sodium
channel
inhibitor
proteas
exampl
furin
cleavag
enac
subunit
activ
channel
reliev
sodium
selfinhibit
activ
requir
subunit
cleav
asp
subunit
play
role
sodium
selfinhibit
mention
recent
studi
show
palmitoyl
subunit
activ
enac
increas
open
probabl
channel
enac
mutant
mutat
significantli
enhanc
sodium
selfinhibit
reduc
open
probabl
compar
wild
type
enac
suggest
enac
palmitoyl
import
posttransl
mechan
channel
regul
exon
within
human
enac
gene
encod
structur
homolog
yet
function
divers
domain
exon
encod
modul
regul
channel
gate
contrast
mutat
larg
elimin
sodium
selfinhibit
respons
reflect
downregul
enac
open
probabl
extracellular
sodium
gainoffunct
human
enac
variant
enhanc
enac
activ
increas
channel
open
probabl
dampen
channel
regul
extracellular
sodium
proteas
renal
handl
sodium
water
abnorm
chronic
kidney
diseas
filtrat
sodium
reabsorb
glomerular
filtrat
potassium
secret
tight
epithelium
kidney
sodium
cross
apic
membran
enter
epitheli
cell
ionselect
enac
enac
respons
reabsorpt
sodium
apic
membran
connect
tubul
collect
duct
play
key
role
control
sodium
balanc
extracellular
fluid
volum
blood
pressur
regul
epitheli
sodium
channel
proteolysi
observ
rat
kidney
human
airway
epithelia
pseudohypoaldosteron
type
monogen
disord
mineralocorticoid
resist
character
saltwast
hyperkalemia
high
aldosteron
level
failur
thrive
autosom
recess
form
pseudohypoaldosteron
type
caus
mutat
enac
usual
associ
sever
persist
multiorgan
symptom
relief
selfinhibit
cptcamp
contribut
acut
effect
addit
wellknown
camppka
signal
pathway
fact
clinic
relev
abnorm
regul
enac
cptcamp
implic
upregul
enac
autosom
recess
pseudohypoaldosteron
type
anoth
distress
transap
sodium
transport
occur
injur
lung
exampl
acut
lung
injuri
ali
acut
respiratori
distress
syndrom
ard
pleas
see
classic
review
apic
enac
contribut
transepitheli
sodium
transport
mammalian
lung
physiolog
condit
critic
process
sensit
aspir
pollut
allergen
pathogen
bacteri
endotoxin
addit
increas
leak
alveolar
microvascular
endothelium
indirect
ali
lung
edema
usus
result
reduc
edema
fluid
resolut
via
enac
direct
ali
enac
promis
target
develop
new
therapeut
strategi
allevi
lung
edema
least
phenotyp
direct
ali
human
serum
cgmp
level
nm
greater
human
bronchoalveolar
lavag
appear
cgmp
may
serv
autocrin
paracrin
regul
enac
function
howev
effect
dose
cptcgmp
cptcamp
blunt
selfinhibit
micromolar
suggest
uncertain
physiolog
role
cgmp
analog
larg
dose
cgmp
compound
mgkg
administ
patient
report
two
clinic
trial
numer
preclin
studi
mm
therefor
feasibl
appli
aerosol
nucleotid
mitig
edemat
lung
injuri
demonstr
cptcgmp
upregul
enac
via
two
mechan
releas
selfinhibit
extern
activ
enac
cgmpcgkii
pathway
intracellularli
thu
compound
could
regul
sodium
absorpt
via
either
mechan
cell
permeabilitydepend
manner
administr
camp
could
potent
pharmaceut
treatment
edemat
lung
injuri
cgmp
may
similar
potenti
cgmp
increas
murin
rat
lung
vivo
vitro
follow
applic
increas
cgmp
may
augment
cgmpsensit
pathway
lung
fluid
remov
alveolar
sac
previou
studi
demonstr
first
time
pkgii
enac
activ
noncili
bronchial
secretori
cell
accordingli
upregul
ratelimit
enac
respiratori
epitheli
cell
specif
pkgii
activ
may
potent
clinicopharmaceut
strategi
allevi
airspac
flood
fatal
edemat
lung
diseas
observ
previou
studi
specif
moieti
requir
activ
enac
may
provid
pivot
inform
develop
potenti
enac
channel
open
structur
relat
would
extrem
use
treat
diseas
associ
lower
enac
function
postul
tight
epitheli
layer
damag
exampl
injur
lung
even
though
mixtur
extracellular
matrix
protein
includ
collagen
albumin
fibrin
seal
epitheli
cellfre
alveolar
surfac
potenc
enac
stimul
limit
significantli
therefor
integr
tight
alveolar
epithelium
key
factor
consid
usag
enac
agonist
anticip
restor
alveolar
fluid
clearanc
may
seen
earlier
stage
ali
lung
edema
mainli
caus
injur
pulmonari
vasculatur
post
regener
alveolar
epithelium
stem
cellsprogenitor
enac
involv
edema
format
kidney
disord
cgmp
either
serv
ligand
regul
cyclic
nucleotideg
ion
channel
act
upstream
pkg
signal
system
role
elimin
enac
selfinhibit
suggest
novel
mechan
cptcgmp
stimul
salt
reabsorpt
compound
specif
pkgii
activ
andor
selfinhibit
inhibitor
could
basi
novel
pharmaceut
intervent
combat
diseas
associ
impair
enac
function
futur
direct
studi
includ
optim
cgmp
structur
potenti
efficaci
activ
enac
evalu
pharmaceut
relev
preclin
clinic
model
impair
enac
activ
confirm
bind
site
cgmp
enac
